• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MAP
Click for more information
4.05% 17.8¢

MICROBA LIFE SCIENCES LIMITED - News & Media

Market Cap $79.49M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Microba Life Sciences Limited is an Australia-based precision microbiome company. The... Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations. More

Articles & Videos

Microba Life Sciences (ASX:MAP) pens distribution agreement with US Luminary Health Centers

Microba Life Sciences (ASX:MAP) has signed a distribution agreement with Luminary Health Centers to deliver a consumer microbiome test in the United States.

07 Feb 2023 12:08 (AEDT)



(20min delay)
Last
17.8¢ 		Change
-0.008(4.05%) 		Mkt cap ! $79.49M
Open High Low Value Volume
18.5¢ 18.5¢ 17.5¢ $14.20K 80.56K

Buyers (Bids)

No. Vol. Price($)
1 45827 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 128369 2
View Market Depth
Last trade - 13.39pm 19/06/2024 (20 minute delay) ?
Last
18.0¢ 		  Change
-0.008 ( 2.70 %)
Open High Low Volume
18.0¢ 18.0¢ 18.0¢ 2019
Last updated 13.39pm 19/06/2024 ?
MAP (ASX) Chart

Top Stories

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

The USA's status as the global leading economy requires a domestic lithium supply chain. Gigafactories and Chariot Corporation mix well.
From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources Fenix Resources is an iron ore producer and logistics company working in the mid west of WA, near Geraldton. Chair John Welborn reveals the milestone volumes which would justify turning from road to rail.
From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources To answer this question from our HotCopper viewer, I spoke with Alderan Resources (ASX:AL8) MD Scott Caithness at the MiningNews Select and Future of Mining conferences in Perth.
Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars AFL great Chris Judd is joined by Jun Bei Liu of Tribeca Investment Partners, who runs the $1.4billion Alpha Trust offshore fund focusing on Australian equities, who has been eyeing dual Nasdaq-ASX listed Life360 with growing interest.The tracking device company has made a significant impact on t...
From the Floor question: "Could gold be manufactured in a lab like diamonds?" Southern Cross Gold GM Lisa Gibbons explains why it's not so easy to manufacture gold in a lab. She argues why it's unlikely this will be a threat to the value of gold.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.